Moric Capsule 7.5 mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of meloxicam orally once daily. The dose may be reduced to 7.5 mg per day according to the response to treatment. Do not administer more than 15 mg of this medicine per day. Take the entire daily dose at once with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions (e.g., history of gastrointestinal disease or cardiovascular risk factors), treatment should usually be initiated at a dose of 7.5 mg per day. ○ In patients with severe renal impairment receiving hemodialysis, do not administer more than 7.5 mg per day.

This medication may pose a risk of gastrointestinal bleeding if taken by individuals who regularly consume more than three glasses of alcohol daily; therefore, consultation with a doctor or pharmacist is essential. This medication can increase the risk of cardiovascular disease, so those with a history or risk factors for heart disease or stroke should carefully monitor their condition. Serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforations may occur; therefore, individuals with a history of gastrointestinal issues or elderly individuals should be particularly cautious. Serious allergic skin reactions, dermatitis, or mucosal lesions may develop; if any skin abnormalities occur, discontinue use immediately and consult healthcare personnel. Kidney function may be affected; individuals with kidney disease or those taking diuretics or blood pressure medications should regularly monitor kidney function while taking this medication. Women who are pregnant or planning to become pregnant should not take this medication, as it may affect reproductive ability and requires caution. This medication may affect blood coagulation; individuals taking anticoagulants or blood-related medications need to consult healthcare personnel due to increased risk of bleeding. Long-term use may require regular liver and kidney function tests; if abnormalities are found, discontinuation is necessary. Additionally, this medication may cause central nervous system symptoms such as drowsiness and dizziness, necessitating caution when driving or operating machinery. In case of overdose, symptoms may include nausea, vomiting, and gastrointestinal bleeding; immediate medical attention is required.

Gastrointestinal bleeding, serious cardiovascular thromboembolic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, exfoliative dermatitis, mucous membrane syndrome, toxic epidermal necrolysis, anaphylactic reaction, interstitial nephritis, glomerulonephritis, renal medullary necrosis, nephrotic syndrome, elevation of serum transaminases, increased liver function values, elevated plasma creatinine, increased blood urea nitrogen, aplastic anemia, bone marrow suppression, changes in blood cell counts, leukopenia, thrombocytopenia, anemia, decreased plasma iron, reduced hemoglobin, decreased hematocrit, increased neutrophils, increased eosinophils, increased basophils, increased monocytes, agranulocytosis, anaphylaxis, discomfort, confusion, loss of direction sense, mood changes, mood disorders, insomnia, nightmares, anxiety, increased appetite, depression, nervousness, dizziness, drowsiness, headache, head pressure, fatigue, lethargy, taste dysfunction, mental confusion, seizures, sensory abnormalities, tremors, blurred vision, conjunctivitis, foreign body sensation in the eye, scleral hemorrhage in the eye, tinnitus, palpitations, elevated blood pressure, flushing, arrhythmia, tachycardia, hypotension, hypertension, myocardial infarction, angina pectoris, heart failure, vasculitis, cough, upper respiratory tract infection, asthma, bronchial spasms, shortness of breath, allergic reactions to aspirin and other non-steroidal anti-inflammatory drugs, dyspepsia, nausea, vomiting, abdominal pain, constipation, bloating, diarrhea, loss of appetite, peptic ulcer, occult or overt gastrointestinal bleeding, stomatitis, gastritis, esophagitis, belching, dry mouth, thirst, angular cheilitis, occult blood in stool, gastrointestinal perforation, colitis, pancreatitis, melena, perforated peptic ulcer, hepatitis, jaundice, liver failure, alopecia, increased sweating, skin rash, urticaria, angioedema, vesicular dermatitis, erythema multiforme, photosensitivity reactions, contact dermatitis, fixed drug eruption, urinary retention, elevated plasma creatinine levels, increased urea levels, decreased total protein, reduced albumin, proteinuria, glucosuria, increased urinary sediment, hematuria, sodium and water retention, hyperkalemia, acute renal failure, reduced urine output, frequency of urination, urinary tract infection, interstitial nephritis, edema, limb swelling, malaise, fever, facial swelling, syncope, weight loss, weight gain, pain in armpit and breast, arthralgia, low back pain, pain in armpit and chest, rigidity, limb weakness, decreased female reproductive capacity, dehydration

This medication is sensitive to light and should be stored in a container that protects from light. It is also recommended to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the drug's efficacy and safety.

Appearance

A hard capsule with a green upper and lower part containing a yellowish powder.

Package unit

30 capsules/bottle, 300 capsules/bottle